CERULEAN PHARMA INC's ticker is CERU and the CUSIP is 15708Q105. A total of 23 filers reported holding CERULEAN PHARMA INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $276,000 | -45.7% | 625,000 | 0.0% | 0.01% | -51.7% |
| Q1 2017 | $508,000 | +14.7% | 625,000 | 0.0% | 0.03% | -3.3% |
| Q4 2016 | $443,000 | -32.3% | 625,000 | 0.0% | 0.03% | -26.8% |
| Q3 2016 | $654,000 | -50.6% | 625,000 | 0.0% | 0.04% | -58.2% |
| Q2 2016 | $1,325,000 | -21.8% | 625,000 | 0.0% | 0.10% | -31.0% |
| Q1 2016 | $1,694,000 | -3.2% | 625,000 | 0.0% | 0.14% | +6.8% |
| Q4 2015 | $1,750,000 | -23.5% | 625,000 | 0.0% | 0.13% | -28.5% |
| Q3 2015 | $2,288,000 | -20.4% | 625,000 | 0.0% | 0.19% | -11.4% |
| Q2 2015 | $2,875,000 | -40.9% | 625,000 | +15.7% | 0.21% | -53.8% |
| Q1 2015 | $4,865,000 | +42.2% | 540,000 | -1.8% | 0.46% | +13.8% |
| Q4 2014 | $3,421,000 | +847.6% | 550,000 | +542.3% | 0.40% | +614.3% |
| Q3 2014 | $361,000 | -27.4% | 85,635 | 0.0% | 0.06% | -37.1% |
| Q2 2014 | $497,000 | – | 85,635 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 3,287,529 | $6,970,000 | 7.48% |
| Polaris Venture Management Co IV LLC | 1,437,441 | $3,047,000 | 5.05% |
| SPHERA FUNDS MANAGEMENT LTD. | 450,000 | $954,000 | 0.25% |
| Deer VII & Co. Ltd. | 166,675 | $353,000 | 0.16% |
| Rock Springs Capital Management LP | 625,000 | $1,325,000 | 0.10% |
| Granahan Investment Management | 708,215 | $1,501,000 | 0.06% |
| Northeast Financial Consultants Inc | 20,000 | $42,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 202,623 | $430,000 | 0.01% |
| WEDBUSH SECURITIES INC | 16,000 | $34,000 | 0.01% |
| Alyeska Investment Group, L.P. | 319,289 | $677,000 | 0.01% |